Abstract
Keywords
Atopic dermatitis; Monoclonal antibody; Janus kinase (JAK) inhibitors
Bibliographic citation
Programa d'Harmonització Farmacoterapèutica. Abrocitinib, baricitinib, tralokinumab i upadacitinib en el tractament de la dermatitis atòpica. Barcelona: Servei Català de la Salut; 2022.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/10453This item appears in following collections
The following license files are associated with this item: